Centogene N.V.

CIK:0001757097|SEC Filings

Consolidated statements of comprehensive loss - EUR (€) € in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Consolidated statements of comprehensive loss
Revenue	€ 48,536	€ 47,473	€ 42,234
Cost of sales	31,287	27,712	28,735
Gross profit	17,249	19,761	13,499
Research and development expenses	12,361	17,488	19,297
General administrative expenses	32,588	32,587	43,480
Selling expenses	12,564	9,924	9,326
Impairment of financial assets	812		827
Gain on reversal of financial asset impairment		432
Other operating income	11,848	3,774	2,894
Other operating expenses	431	741	86
Operating loss	(29,659)	(36,773)	(56,623)
Losses from investments accounted for by the Equity method	(302)
Gains/(losses) on changes in fair value of warrants	(159)	2,574
Interest and similar income	3,293	512	3
Interest and similar expenses	8,418	4,909	802
Total Financial costs, net	(5,284)	(1,823)	(799)
Loss before taxes from continuing operations	(35,245)	(38,596)	(57,422)
Income taxes expenses	287	107	(70)
Loss for the year from continuing operations	(35,532)	(38,703)	(57,352)
Net income from discontinued operations, net of tax		6,862	11,106
Loss for the period	(35,532)	(31,841)	(46,246)
Other comprehensive income/(loss), all attributable to equity holders of the parent	(271)	(76)	543
Total comprehensive loss	(35,803)	(31,917)	(45,703)
Attributable to:
Equity holders of the parent	(35,803)	(31,917)	(45,801)
Noncontrolling interests from continuing operations			98
Total comprehensive loss	€ (35,803)	€ (31,917)	€ (45,703)
Net loss per share - Continuing operations - Basic (in EUR)	€ (1.27)	€ (1.45)	€ (2.53)
Net loss per share - Continuing operations - Diluted (in EUR)	(1.27)	(1.45)	(2.53)
Net loss per share - Loss attributable to parent - Basic (in EUR)	(1.27)	(1.19)	(2.04)
Net loss per share - Loss attributable to parent - Diluted (in EUR)	€ (1.27)	€ (1.19)	€ (2.04)

Consolidated statements of cash flows - EUR (€) € in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Operating activities
Loss before taxes from continuing operations	€ (35,245)	€ (38,596)	€ (57,422)
Income before taxes from discontinued operations		6,875	11,152
Loss before taxes	(35,245)	(31,721)	(46,270)
Adjustments to reconcile earnings to cash flow from operating activities
Amortization (including impairments) and depreciation	7,610	10,378	19,974
Government grant depreciation	(1,265)
Inventory write-off	226		1,795
Interest income	(209)		(3)
Interest expense	8,201	4,909	851
Gain on the disposal of property, plant and equipment	(56)	(754)	(18)
Gain on the sales of IP to Joint Venture	(7,549)
Expected credit loss allowances on trade receivables and contract assets	761		827
Sharebased payment expenses	2,929	(16)	8,035
Tax Expense		(89)
Profit or loss from financial instruments FV adjustments	(263)	(2,574)
Loss from Joint Venture equity method	302
Other noncash items	(34)	(1,430)	(821)
Net foreign exchange differences	(2,438)	963
Interest received	209
Changes in operating assets and liabilities:
Inventories	(870)	2,050	5,741
Trade receivables and contract assets	(3,628)	6,914	4,855
Other assets	1,858		1,828
Trade payables	(689)	(4,935)	(20,484)
Other liabilities	(1,599)	(10,182)	1,952
Thereof cash flow (used in) continuing operating activities	(31,749)	(35,497)	(42,635)
Thereof cash flow from discontinued operating activities		9,009	20,897
Cash flow (used in)/from operating activities	(31,749)	(26,488)	(21,739)
Investing activities
Cash paid for investments in intangible assets	(2,239)	(1,727)	(2,787)
Cash paid for investments in property, plant and equipment	(40)	(367)	(2,915)
Cash paid for investment in Joint Venture	(4,973)
Grants received for investment in property, plant and equipment	0	506	168
Cash received from the disposals of property, plant and equipment	93	855	171
Cash received from sale of IP to Joint Venture	9,436
Interest received			3
Thereof cash flow from/(used) in continuing investing activities	2,277	(1,553)	(2,494)
Thereof cash flow from/(used in) discontinued investing activities		820	(2,866)
Cash flow used in investing activities	2,277	(733)	(5,360)
Financing activities
Cash received from the issuance of shares		12,140
Cash received from issuance of warrants		2,833
Cash paid for acquisition of non-wholly owned subsidiary		(1)
Cash received from loans	25,500	40,568	1,772
Cash repayments of loans	(3,374)		(464)
Cash repayments of lease liabilities	(3,095)	(4,314)	(4,244)
Interest paid	(5,987)	(4,909)	(267)
Thereof net cash flow from/(used in) continuing financing activities	13,044	46,798	(2,403)
Thereof net cash flow used in discontinued financing activities		(481)	(800)
Cash flow from financing activities	13,044	46,317	(3,203)
Changes in cash and cash equivalents	(16,428)	19,096	(30,302)
Cash and cash equivalents at the beginning of the period	35,951	17,818	48,156
Effect of movements in exchange rates on cash held	(424)	(963)	(36)
Cash and cash equivalents at the end of the period	€ 19,099	€ 35,951	€ 17,818

Consolidated statements of financial position - EUR (€) € in Thousands	Dec. 31, 2023	Dec. 31, 2022
Noncurrent assets
Intangible assets	€ 6,850	€ 7,400
Property, plant and equipment	5,643	6,808
Right-of-use assets	13,635	15,351
Investment in Joint Venture	2,784
Derivative assets	799	510
Other assets	3,425	2,911
Non-current assets	33,136	32,980
Current assets
Inventories	2,463	1,819
Trade receivables and contract assets	19,415	16,548
Other assets	3,042	5,514
Cash and cash equivalents	19,099	35,951
Current assets	44,019	59,832
Assets	77,155	92,812
Equity
Issued capital	3,478	3,307
Capital reserve	148,308	145,369
Accumulated deficit and other reserves	(177,068)	(141,265)
Noncontrolling interests	0
Equity	(25,282)	7,411
Noncurrent liabilities
Noncurrent loans	39,880	40,051
Lease liabilities	12,399	13,125
Deferred tax liabilities	407	35
Government grants	5,701	6,687
Derivative liabilities	242	376
Warrant liability	394	260
Other liabilities	48	202
Non-current liabilities	59,071	60,736
Current liabilities
Government grants	984	1,263
Current loans	25,882	4,635
Lease liabilities	2,178	2,311
Liabilities from income taxes	87	89
Trade payables	5,628	6,317
Other liabilities	8,607	10,050
Current liabilities	43,366	24,665
Equity and liabilities	€ 77,155	€ 92,812